Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: Case report and review of literature

Therapeutic Advances in Neurological Disorders

Volumn 9, Issue 3, 2016, Pages 211-215

  Dubey, Divyanshu ^a   Zhang, Yinan ^a   Graves, Donna ^a   DeSena, Allen D ^a   Frohman, Elliot ^b   Greenberg, Benjamin ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Immune Reconstitution Inflammatory Syndrome; Interleukin 2; Multiple sclerosis; Natalizumab; Progressive multifocal leukoencephalopathy

Indexed keywords

ETIRACETAM; IMMUNOGLOBULIN; INTERLEUKIN 2; MEFLOQUINE; MEPREDNISONE; NATALIZUMAB;

ADULT; APHASIA; CASE REPORT; CEREBROSPINAL FLUID; DRUG WITHDRAWAL; FEMALE; HEMIPARESIS; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; JC VIRUS; LUMBAR PUNCTURE; MIDDLE AGED; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; SEIZURE;

EID: 84962236076     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285615621029     Document Type: Review

References (8)

1. Aksamit A. Jr., (2012) Progressive multifocal leukoencephalopathy. Continuum 18: 1374-1391.
2. Buckanovich R., Liu G., Stricker C., Luger S., Stadtmauer E., Schuster S., et al. (2002) Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy. Ann Hematol 81: 410-413.
3. Calabrese L., (2011) A rational approach to PML for the clinician. Clev Clin J Med 78 (Suppl. 2): S38-S41.
4. Dubey D., Zhang Y., Graves D., DeSena A. D., Frohman E., Greenberg B., (in press) Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature. Therapeutic Advances in Neurological Disorders DOI: 10.1177/1756285615621029.
5. Kunschner L., Scott T., (2005) Sustained recovery of progressive multifocal leukoencephalopathy after treatment with IL-2. Neurology 65: 1510.
6. Lotze M., Matory Y., Rayner A., Ettinghausen S., Vetto J., Seipp C., et al. (1986) Clinical effects and toxicity of interleukin-2 in patients with cancer. Cancer 58: 2764-2772.
7. Przepiorka D., Jaeckle K., Birdwell R., Fuller G., Kumar A., Huh Y., et al. (1997) Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant 20: 983-987.
8. Smith K., (1984) Interleukin 2. Annu Rev Immunol 2: 319-333.